We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT03292783
Brief Title: This is a Study to Evaluate the Safety and Tolerability of the Study Drug ABL001, and to Determine the Maximum Tolerated Dose and/or Recommended Phase 2 Study Dose of ABL001

First Submitted : September 21, 2017
First Submitted that Met QC Criteria : September 21, 2017
First Posted : September 26, 2017

Last Update Submitted that Met QC Criteria : July 4, 2021
Last Update Posted : July 7, 2021